Aprea Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.75

-0.01 (-1.18%)

As of Sep 28, 10:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +4,696.5% upside

Low Target $23.45

Average Target $36.06

High Target $38.88

Current Price $0.75

Current
$0.75

Target
$36.06

$23.45 $36.06 avg $38.88

Scenario Analysis

Bear Case

$23.45

3,019.2%

Low target

Base Case

$36.06

+4,696.5%

Avg target

Bull Case

$38.88

+5,071.6%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.69

-55.5% from high

52-Week Low

$0.55

+37.2% from low

Target vs 52W High

$36.06

+2,033.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%